Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 36, 2006 - Issue 12
Submit an article Journal homepage
106
Views
5
CrossRef citations to date
0
Altmetric
Original

Glucuronidation in the chimpanzee (Pan troglodytes): Studies with acetaminophen, oestradiol and morphine

H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
D. D. Christ Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
&
D. D. Christ Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
 show all
Pages 1178-1190 | Received 10 Jun 2006, Accepted 15 Jul 2006, Published online: 11 Aug 2009

References

  • Alkharfy KM, Frye RF. High-performance liquid chromatography assay for acetaminophen glucuronide in human liver microsomes. Journal of Chromatography B: Biomedical Science Applications 2001; 753: 303–308
  • Alkharfy KM, Frye RF. Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: Formation kinetics. Journal of Chromatography B: Analytical and Technology of the Biomedical Life Sciences 2002; 774: 33–38
  • Ausubel FM, Brent R, Kinfston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology. Green/Wiley-Interscience, New York, NY 1994
  • Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metabolism and Disposition 1997; 25: 1–4
  • Court MH, Duan SX, Von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. Journal of Pharmacology and Experimental Therapy 2001; 299: 998–1006
  • Court MH, Greenblatt DJ. Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochemistry and Pharmacology 1997; 53: 1041–1047
  • Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, Greenblatt DJ. Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: Specificity and influence of the UGT2B7*2 polymorphism. Drug Metabolism and Disposition 2003; 31: 1125–1133
  • Fischer LJ, Thies RL, Charkowski D, Donham KJ. Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans. Drug Metabolism and Disposition 1980; 8: 422–424
  • Fisher MB, Campanale K, Ackermann BL, Vandenbranden M, Wrighton SA. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metabolism and Disposition 2000; 28: 560–566
  • Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metabolism Reviews 2001; 33: 273–297
  • Forrest JAH, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clinical Pharmacokinetics 1982; 7: 93–107
  • Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL, Mackenzie PI, Radominska-Pandya A. Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. Journal of Steroid Biochemistry and Molecular Biology 1999; 70: 101–108
  • Gibaldi M, Perrier D. Pharmacokinetics2nd. Marcel Dekker, New York, NY 1982
  • Iqbal N, Ahmad B, Janbaz KH, Gilani A-UH, Niazi SK. The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharmacology and Drug Disposition 1995; 16: 481–487
  • King C, Finley B, Franklin R. The glucuronidation of morphine by dog liver microsomes: Identification of morphine-6-O-glucuronide. Drug Metabolism and Disposition 2000; 28: 661–663
  • Lake BG. Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. Biochemical toxicology: A practical approach, K Snell, B Mulloch. IRL Press, Oxford 1987; 183–216
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagents. Journal of Biology and Chemistry 1951; 193: 265–275
  • Metzler M. Metabolic activation of carcinogenic diethylstilbestrol in rodents and humans. Journal of Toxicology and Environmental Health 1976; S1: 21–35
  • Metzler M, Muller W, Hobson WC. Biotransformation of Diethylstibestrol in the rhesus monkey and the chimpanzee. Journal of Toxicology and Environmental Health 1977; 3: 439–450
  • Radominska-Pandya, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metabolism Reviews 1999; 31: 817–899
  • Riska P, Lamson M, MacGregor T, Sabo J, Hattox S, Pav J, Keirns J. Disposition and biotransformation of the antiretroviral drug nevirapine in humans. Drug Metabolism and Disposition 1999a; 27: 895–901
  • Riska PS, Joseph DP, Dinallo RM, Davidson WC, Keirns JJ, Hattox SE. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Drug Metabolism and Disposition 1999b; 27: 1434–1447
  • Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochemistry Journal 1994; 303: 233–240
  • Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighten SA. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition 1995; 23: 1231–1241
  • Soars MG, Riley RJ, Burchell B. Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica 2001; 31: 849–860
  • Thomas BH, Wong LT, Hynie I, Zeitz W. Metabolism of 14C-ring-labelled paracetamol in humans. Biochemistry Society Transactions 1975; 3: 687–688
  • Wang LH, Rudolph AM, Benet L. Pharmacokinetic studies of the disposition of acetaminophen in the sheep maternal–placental–fetal unit. Journal of Pharmacology and Experimental Therapy 1986; 236: 198–205
  • Wildman DE. A map of the common chimpanzee genome. BioEssays 2002; 24: 490–493
  • Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalysed estradiol-3-glucuronidation by the addition of UGT 1A1 substrates and other compounds to human liver microsomes. Drug Metabolism and Disposition 2002; 30: 1266–1273
  • Wong H, Grossman SJ, Bai SA, Diamond S, Wright MR, Grace Jr JE, Qian M, He K, Yeleswaram K, Christ DD. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: Model characterization and application. Drug Metabolism and Disposition 2004; 32: 1359–1369

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.